Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitus.

The Journal of the American Osteopathic Association

Volumn 107 Suppl, Issue , 2007, Pages

  Boyle, Patrick J ^a   Freeman, Jeffrey S ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV; DRUG DERIVATIVE; EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; LIRAGLUTIDE; PEPTIDE; VENOM;

DOSE RESPONSE; DRUG ADMINISTRATION; DRUG ANTAGONISM; FEMALE; HUMAN; HYPERGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROBABILITY; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ANTIGENS, CD26; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; PEPTIDES; PROBABILITY; PROGNOSIS; TREATMENT OUTCOME; VENOMS;

EID: 35348834158     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)